36
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11481 |
GSK2239633A
|
CCR | Immunology/Inflammation; Microbiology/Virology |
GSK2239633A 是趋化因子受体 CCR4 的变构拮抗剂,将 [125I]-TARC 与人 CCR4 结合的 pIC50 为 7.96。 | |||
T5384 |
RS 504393
|
CCR | Immunology/Inflammation; Microbiology/Virology |
RS 504393 是一种高度选择性的 CCR2 趋化因子受体拮抗剂,作用于人重组 CCR2 和 CCR1 受体,IC50值分别为 89 nM 和大于 100 μM。 | |||
TQ0283 |
RS102895
|
CCR | Immunology/Inflammation; Microbiology/Virology |
RS102895 是一种CCR2拮抗剂,IC50值为 360 nM。 | |||
T4300 |
AZD2098
|
CCR | Immunology/Inflammation; Microbiology/Virology |
AZD2098 是选择性CCR4抑制剂,可用于哮喘研究,对人类、大鼠、小鼠和狗的 CCR4 pIC50 值分别为 7.8、8.0、8.0和7.6。 | |||
T4674 |
SB297006
SB 297006 |
CCR | Immunology/Inflammation; Microbiology/Virology |
SB297006 是一种CCR3拮抗剂,IC50为39 nM。它能够显著抑制 CCL11 处理的神经祖细胞的增殖和神经球形成。 | |||
TQ0103 |
INCB3344
|
CCR | Immunology/Inflammation; Microbiology/Virology |
INCB3344 是一种有效、特异性和口服生物可利用的 CCR2 拮抗剂,结合拮抗作用的 IC50 值为 9.5 nM (mCCR2) 和 5.1 nM (hCCR2),趋化活性拮抗作用的 IC50 值为 7.8 nM (mCCR2) 和 3.8 nM (hCCR2)。 | |||
T30258 |
AZD-4818
CCR1 antagonist |
CCR | Immunology/Inflammation; Microbiology/Virology |
AZD-4818 (CCR1 antagonist) 是趋化因子CCR1的一种拮抗剂,可用于研究慢性阻塞性肺病。 | |||
T24700 |
R243
R 243,R-243 |
CCR | Immunology/Inflammation; Microbiology/Virology |
R243 是选择性的CCR8拮抗剂,可抑制CCL1/CCR8的相互作用,以及CCR8信号传导和趋化性,具有抗伤害感受和抗炎作用。 | |||
T7499 |
TAK-779
Takeda 779 |
HIV Protease; CXCR; CCR | Autophagy; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
TAK-779 (Takeda 779) 是一种非肽类CCR5和CXCR3 拮抗剂,对CCR5的Ki 值为 1.1 nM,并选择性抑制R5 HIV-1。 | |||
T10425 |
AZ084
|
CCR | Immunology/Inflammation; Microbiology/Virology |
AZ084 是可口服的选择性 CCR8变构拮抗剂,其Ki 值为 0.9 nM,可研究哮喘。 | |||
T16111 |
ML604086
|
CCR | Immunology/Inflammation; Microbiology/Virology |
ML604086 是选择性CCR8抑制剂,抑制循环T 细胞上 CCL1 与 CCR8 结合,还抑制 CCL1 介导的趋化性并提高细胞内 Ca2 浓度。 | |||
T16091 |
MK-0812 Succinate
|
Others; CCR | Immunology/Inflammation; Microbiology/Virology; Others |
MK-0812 Succinate 是一种选择性CCR2拮抗剂。 | |||
T11699 |
J-113863
|
CCR | Immunology/Inflammation; Microbiology/Virology |
J-113863 是选择性的 CCR1 (CD18)拮抗剂,有抗炎作用,对人和小鼠 CCR1受体的 IC50值分别为 0.9 和 5.8 nM。它是人 CCR3的强效拮抗剂,还是小鼠 CCR3的弱效拮抗剂,IC50分别为 0.58 和 460 nM。 | |||
T4584 |
BMS-813160
BMS 813160 |
CCR | Immunology/Inflammation; Microbiology/Virology |
BMS-813160 是CCR2/CCR5双重拮抗剂。有用于心血管的研究潜力。 | |||
T12773 |
RS102895 hydrochloride
RS102895盐酸盐 |
Others; 5-HT Receptor; CCR | GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience; Others |
RS102895 hydrochloride 是一种CCR2拮抗剂,IC50值为 360 nM。 | |||
T3430 |
PF-4136309
INCB8761,PF 4136309 |
CCR | Immunology/Inflammation; Microbiology/Virology |
PF-4136309 (INCB8761) 是一种高效选择性和可口服的 CCR2拮抗剂,能够抑制人、小鼠和大鼠 CCR2,IC50值分别为 5.2、17 和 13 nM。 | |||
T2375 |
BX471
BX 471,BX-471,ZK-811752 |
CCR | Immunology/Inflammation; Microbiology/Virology |
BX471 (BX 471) 是可口服的非多肽 CCR1选择性拮抗剂,Ki 值为 1 nM,对其选择性是对 CCR2、CCR5 和 CXCR4 的 250 倍。 | |||
T17225 |
Vercirnon
CCX282-B,维塞诺,GSK-1605786,Traficet-EN |
CCR | Immunology/Inflammation; Microbiology/Virology |
Vercirnon (Traficet-EN) 是可口服的选择性 CCR9拮抗剂,可抑制 CCR9 介导的 Molt-4 细胞上 Ca2+移动和趋化性,用于炎症性肠病的研究。 | |||
T10639 |
C-021 dihydrochloride
|
CCR | Immunology/Inflammation; Microbiology/Virology |
C-021 dihydrochloride 是一种有效的 CCR4 拮抗剂。 它有效抑制人和小鼠的功能趋化性,IC50 为 140 nM 和 39 nM。 | |||
T6016 |
Maraviroc
Celsentri,马拉维若,UK-427857,Selzentry |
HIV Protease; CCR | Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Maraviroc (Selzentry) 是一种 C-C 趋化因子受体 5 拮抗剂,具有抑制HIV 的活性。 | |||
T7624 |
DAPTA
DAPTA(TFA),D-Ala-peptide T-amide,Adaptavir |
HIV Protease; CCR | Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
DAPTA (Adaptavir) 是一种合成肽,是 CCR5抑制剂,有抗 HIV 的活性。 | |||
TQ0297 |
Cenicriviroc
TAK-652,TBR-652 |
HIV Protease; CCR | Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Cenicriviroc (TAK-652) 是一种可口服的CCR2/CCR5拮抗剂,可抑制 HIV-1 和 HIV-2,具有抗炎、抗感染作用。 | |||
T13114 |
CCR2 antagonist 4
Teijin compound 1 |
CCR | Immunology/Inflammation; Microbiology/Virology |
CCR2 antagonist 4 (Teijin compound 1) 是高效的、特异性的CCR2拮抗剂,对 CCR2b 的IC50为 180 nM,抑制 MCP-1 诱导的趋化作用的 IC50为 24 nM。 | |||
T21870 |
C-021
4-Quinazolinamine, 2-[1,4'-bipiperidin]-1'-yl-N-cycloheptyl-6,7-dimethoxy- |
CCR | Immunology/Inflammation; Microbiology/Virology |
C 021 dihydrochloride 是一种 CC 趋化因子受体 4 (CCR4) 拮抗剂,抑制人和小鼠的功能趋化性,IC50分别为 140 和 39 nM。C-021 (4-Quinazolinamine, 2-[1,4'-bipiperidin]-1'-yl-N-cycloheptyl-6,7-dimethoxy-) 可有效阻止人 CCL22 衍生的 [35S]GTPγS 与受体结合,IC50为 18 nM。 | |||
T14900 |
CCR2-RA-[R]
(5R)-4-乙酰基-1-(4-氯-2-氟苯基)-5-环己基-1,5-二氢-3-羟基-2H-吡咯-2-酮 |
CCR | Immunology/Inflammation; Microbiology/Virology |
CCR2-RA-[R] 是一种 C-C 趋化因子受体 2 型 (CCR2) 变构拮抗剂,IC50值为103 nM。 | |||
T3435 |
Vicriviroc maleate
维立韦罗马来酸盐,SCH-D (maleate),SCH-417690 (maleate) |
HIV Protease; CCR | Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Vicriviroc maleate (SCH-417690 (maleate)) 是一种可口服,可透过血脑屏障的 CCR5选择性拮抗剂,同时抑制外周血单核细胞中的 HIV-1 的活性。 | |||
T2386 |
Pirfenidone
S-7701,AMR-69,S-7701,AMR69,吡非尼酮 |
CCR; TGF-beta/Smad | Immunology/Inflammation; Microbiology/Virology; Stem Cells |
Pirfenidone (AMR69) 是一种抗纤维化剂,可减弱纤维细胞中CCL2和CCL12的产生。它可抑制细胞生长,并能降低人胶质瘤细胞系中的TGF-β2蛋白水平,具有抗炎活性。 | |||
T76782 |
Mogamulizumab
KW-0761 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Mogamulizumab (KW-0761) 是一种针对 T 细胞 CC 趋化因子受体 4 的 单克隆抗体。Mogamulizumab 具有抗癌活性,通过抗体依赖性细胞毒性 (ADCC) 消除肿瘤细胞,可用于研究癌症、成人T细胞白血病/淋巴瘤 (ATLL)、皮肤T细胞淋巴瘤(CTCL)。 | |||
T68984 |
AF-399/42018025
|
||
AF-399/42018025 is a CC chemokine receptor 4 (CCR4) antagonist. | |||
T29181 |
YM-355179
YM 355179 |
||
YM-355179 is a novel, selective antagonist of CC chemokine receptor 3 with oral activity. | |||
T69830 |
GSK2239633
|
||
GSK2239633 is a potent CC-chemokine receptor 4 antagonist with pIC50 of 7.9. The CC-chemokine receptor 4 (CCR4) is thought potentially to play a critical role in asthma pathogenesis due to its ability to recruit type 2 T-helper lymphocytes to the inflamed airways. Therefore, CCR4 provides an excellent target for anti-inflammatory therapy. | |||
T26642 |
Aplaviroc hydrochloride
AK602,AK 602,GW873140A,GW-873140,GW873140,AK-602,Aplaviroc HCl |
||
Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc | |||
T10716 |
CCR7 Ligand 1
CCR7-Cmp2105 |
Others | Others |
CCR7 Ligand 1 (CCR7-Cmp2105) is an allosteric Ligand and antagonist for human CC chemokine receptor 7 (CCR7) with a Kd of 3 nM. CCR7 Ligand 1, thiadiazole-dioxide ligan, suppresses arrestin binding in response to activation by CCL19 with an IC50 of 7.3 μM | |||
T10713 | CCR4 antagonist 2 | Calcium Channel | Membrane transporter/Ion channel; Metabolism |
CCR4 antagonist 2 (Compound 31) is a novel potent, orally bioavailable small molecule antagonists of CC chemokine receptor 4 (CCR4) that inhibits Treg trafficking into the Tumor Microenvironment without suppressing the number of Treg in healthy tissues. CCR4 antagonist 2 (Compound 31) exhibits IC50 values of Ca2+flux and (chemotaxis) CTX are 40 nM and 70 nM, respectively. | |||
T69523 | BMS-681 | ||
BMS-681 is an orthosteric antagonist of chemokine receptor 2 (CCR2) that forms a ternary complex with CCR2 and its allosteric antagonist, CCR2-RA-[R]. Together, the complex inhibits chemokine binding with BVMS-681 in the orthosteric pocket and CCR2-RA-[R] in the intracellular allosteric G-protein binding site. When chemokine binding is inhibited, modulation responses implicated in several inflammatory and neurodegenerative diseases, including atherosclerosis, multiple sclerosis, asthma, neuropat... | |||
T69081 | KRH-1636 | ||
KRH-1636 is an orally active, selective and extremely potent CXC chemokine receptor 4 antagonist. KRH-1636 exhibits a potent and selective anti-HIV-1 activity. KRH-1636 efficiently blocked replication of various T cell line-tropic (X4) HIV type 1 (HIV-1) in MT-4 cells and peripheral blood mononuclear cells through the inhibition of viral entry and membrane fusion via the CXC chemokine receptor (CXCR)4 coreceptor but not via CC chemokine receptor 5. KRH-1636 also inhibits binding of the CXC chem... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6413 |
Bindarit
宾达利,AF2838 |
CCR | Immunology/Inflammation; Microbiology/Virology |
Bindarit (AF2838) 是单核细胞趋化蛋白MCP-1/CCL2,MCP-3/CCL7和MCP-2/CCL8的选择性抑制剂,具有抗炎作用。 | |||
TN1273 |
7,4'-Dihydroxyflavone
4',7-Dihydroxyflavone,7,4'-二羟基黄酮 |
NF-κB; COX; HDAC; CCR; NOD | Chromatin/Epigenetic; DNA Damage/DNA Repair; Immunology/Inflammation; Microbiology/Virology; Neuroscience; NF-κB |
7,4'-Dihydroxyflavone (4',7-Dihydroxyflavone) 是从甘草中分离的类黄酮,是 eotaxin/CCL11抑制剂,抑制嗜酸性粒细胞趋化因子产生。它通过调节 NF-κB、STAT6 和 HDAC2,抑制 MUC5A 基因表达和粘液产生。 |